Cargando…

Ultrahypofractionation of localized prostate cancer: Statement from the DEGRO working group prostate cancer

Due to its low fractionation sensitivity, also known as “alpha/beta ratio,” in relation to its surrounding organs at risk, prostate cancer is predestined for hypofractionated radiation schedules assuming an increased therapeutic ratio compared to normofractionated regimens. While moderate hypofracti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolf, Frank, Sedlmayer, Felix, Aebersold, Daniel, Albrecht, Clemens, Böhmer, Dirk, Flentje, Michael, Ganswindt, Ute, Ghadjar, Pirus, Höcht, Stefan, Hölscher, Tobias, Müller, Arndt-Christian, Niehoff, Peter, Pinkawa, Michael, Schmidt-Hegemann, Nina-Sophie, Zamboglou, Constantinos, Zips, Daniel, Wiegel, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726607/ https://www.ncbi.nlm.nih.gov/pubmed/33301049 http://dx.doi.org/10.1007/s00066-020-01723-8

Ejemplares similares

Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer: Statement from the DEGRO working group prostate cancer
por: Ghadjar, Pirus, et al.
Publicado: (2020)

Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries: A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO)
por: Shelan, Mohamed, et al.
Publicado: (2021)

Radiotherapy in nodal oligorecurrent prostate cancer
por: Pinkawa, Michael, et al.
Publicado: (2021)

Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases
por: Müller, Arndt-Christian, et al.
Publicado: (2022)

MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation
por: Benitez, Cecil M., et al.
Publicado: (2023)

Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial
por: Müller, Arndt-Christian, et al.
Publicado: (2015)

Prostate Ultrahypofractionation – Rising to Challenges Presents Opportunities in the COVID-19 Era
por: Griffiths, W., et al.
Publicado: (2021)

Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage
por: Wegener, Daniel, et al.
Publicado: (2022)

Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients
por: Ishiyama, Hiromichi, et al.
Publicado: (2021)

Radiotherapy in oligometastatic prostate cancer—a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO)
por: Rogowski, Paul, et al.
Publicado: (2022)

DEGRO practical guideline for partial-breast irradiation
por: Strnad, V., et al.
Publicado: (2020)

A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2021)

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
por: Dal Pra, Alan, et al.
Publicado: (2023)

Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer
por: Mohajer, Jonathan, et al.
Publicado: (2020)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking
por: Ghadjar, Pirus, et al.
Publicado: (2008)

ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy
por: Dirix, Piet, et al.
Publicado: (2023)

Postoperative Radiotherapy after Radical Prostatectomy: Indications and Open Questions
por: Ghadjar, Pirus, et al.
Publicado: (2012)

Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer
por: Ghadjar, Pirus, et al.
Publicado: (2014)

Abstracts DEGRO 2017
Publicado: (2017)

Abstracts DEGRO 2021
Publicado: (2021)

Abstracts DEGRO 2022
Publicado: (2022)

Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)
por: Beck, Marcus, et al.
Publicado: (2021)

Prevention of radiochemotherapy-induced toxicity with amifostine in patients with malignant orbital tumors involving the lacrimal gland: a pilot study
por: Goldblum, David, et al.
Publicado: (2008)

Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultrahypofractionated Stereotactic Body Radiotherapy
por: Milecki, Piotr, et al.
Publicado: (2023)

Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy
por: Cihoric, Nikola, et al.
Publicado: (2012)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2021)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences
por: Harms, Wolfgang, et al.
Publicado: (2016)

Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin
por: Baumunk, Daniel, et al.
Publicado: (2013)

Treatment planning comparison of high-dose-rate brachytherapy vs. robotic and conventional stereotactic body radiotherapy for ultrahypofractionated treatment of prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2023)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

DEGRO practical guidelines: radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer
por: Sedlmayer, F., et al.
Publicado: (2013)

Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure
por: Geretschläger, Andreas, et al.
Publicado: (2015)

Treatment of Locally Advanced Prostate Cancer: A Case Report and Narrative Review
por: Peinemann, Frank, et al.
Publicado: (2012)

Gastrointestinal Quality-of-Life Trajectories after Radiotherapy for Prostate Cancer—Which Patients Suffer from Persisting Problems?
por: Pinkawa, Michael
Publicado: (2023)

Outcome and patterns of failure after postoperative intensity modulated radiotherapy for locally advanced or high-risk oral cavity squamous cell carcinoma
por: Geretschläger, Andreas, et al.
Publicado: (2012)

Editorial: Exploring the Potential of PSMA-PET Imaging on Personalized Prostate Cancer Treatment
por: Ilhan, Harun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3jdtka9s67d5ep52ogolb9hq71